Clinical Trial Update: Selinexor in Initial or Refractory and/or Relapsed Richter's Transformation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for selinexor in Richter's transformation (initial or refractory/relapsed); study terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Richter Transformation

Drugs mentioned

• Selinexor (selinexor)

Snippet

Sponsor: Karyopharm Therapeutics Inc | Conditions: Richter's Transformation | Phase 2 | Status: TERMINATED | Results posted: 2020-02-11